Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

Clinical trial NCT05941156 · UNKNOWN

Trial details

NCT number: NCT05941156
Sponsor: The Affiliated Hospital of Xuzhou Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Extranodal NK T Cell Lymphoma NK-Cell Leukemia

Start date: 2023-05-01
Primary completion: 2026-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.